Currently, I work for Myriad Genetic Laboratories, and if you haven't heard of Myriad this summer, I would be surprised. This past June, the Supreme Court ruled that five of Myriad's claims covering isolated DNA were not patent eligible. Regardless of the decision, Myriad has more than 500 valid and enforceable claims in 24 different … Continue reading Committed.
Welcome to the final entry in my mini-series "Are you there, Pharma? It's me, Liz," about creativity squashers in the pharmaceutical industry. Part one included a short overview of the uncertainty this industry is facing and a decree for strategic integration of social strategies. It also suggested that pharma must begin to, "Listen and Act." Part two … Continue reading Are you there, Pharma? It’s me, Liz. Part 3: making real change in 2013
Welcome back to the second post in my series, "Are you there Pharma? It's me, Liz." This series identifies creative thinking squashers in Pharma and suggests strategic changes that will help Big Pharma to improve its business model, in hopes of radically changing the way Pharma goes about its business. The first post discussed … Continue reading Are you there Pharma? It’s me, Liz. Part two: What’s Killing Creativity in Big Pharma Sales Forces?